Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225732 · ClinicalTrials.gov registry record · Phase 3
Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients
A Phase 3 study, sponsored by Cumberland Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 319
- Enrollment target
NCT00225732 is a Phase 3 study that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 319 participants.
The verdict
NCT00225732, a Phase 3 study, has completed, sponsored by Cumberland Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 319 participants
- Enrollment target
Study Summary
The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for the narcotic analgesic, morphine, post surgery
Interventions
- DRUG Intravenous ibuprofen
- OTHER Normal saline as placebo comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00225732
The ClinicalTrials.gov registry entry for NCT00225732 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 319 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intravenous ibuprofen is the first listed.
NCT00225732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00225732 about?
NCT00225732 is a clinical study titled "Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients". The primary objective of this study of Caldolor (IV ibuprofen) administered to post-operative hospitalized adult patients every 6 hours for 48 hours is to determine the efficacy of Caldolor compared to placebo for the treatment of post-operative pain as measured by reduction in the requirement for t...
What is the current status of trial NCT00225732?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 319 participants. The study started on 2005-01. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00225732?
The interventions under investigation include: Intravenous ibuprofen (DRUG), Normal saline as placebo comparator (OTHER).
Who is sponsoring clinical trial NCT00225732?
This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.